A Bioequivalence Study of Hetrombopag in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 25, 2021

Primary Completion Date

July 25, 2022

Study Completion Date

November 2, 2023

Conditions

Sever Aplastic Anaemia

Interventions

DRUG

Hetrombopag Olamine Tablet

Hetrombopag Olamine Tablet (T: test formulation) Hetrombopag Olamine Tablet (R: reference formulation)

Trial Locations (1)

The People's Hospital Of Liaoning Province, Shenyang

All Listed Sponsors

lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY